secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonoma Pharmaceuticals, Inc. (SNOA)
CIK:        0001367083
Form:       8-K/A
Filed at:   2023-10-11T23:59:59+00:00
Accession:  0001683168-23-007057
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonoma Pharmaceuticals files amended 8-K with updated investor presentation; no material new information
--------------------------------------------------------------------------------

- Amended filing corrects item number from original 8-K dated October 11, 2023.
- Investor presentation (October 2023) describes stabilized hypochlorous acid products for dermatology, wound care, etc.
- Products are sold directly or via partners in 55 countries; company actively seeks distribution partners.
- Presentation contains no financial results, guidance, or material operational updates.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367083/000168316823007057/0001683168-23-007057-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367083/000168316823007057/sonoma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-007057

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer